Eijiro Miyako

Associate Professor

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eijiro Miyako is an Associate Professor at the Japan Advanced Institute of Science and Technology (JAIST) in Japan. His research focuses on innovative therapeutic applications in cancer treatment, including the development of brain-targeting peptides and the use of bacterial systems for oncolytic therapy. Recent publications highlight his work on multifunctional nanomaterials and their integration in cancer photothermo-chemo-immunotherapy.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Eri Hirata

Assistant professor

Hokkaido University

JAPAN

View details

Robin Rajan

Assistant Professor

Japan Advanced Institute of Science and Technology

JAPAN

View details

Cécilia Ménard‐Moyon

FRANCE

View details

Yuta Takano

Assoc Prof.

Hokkaido University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eijiro Miyako

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

A Next-Generation Brain-Targeting Peptide: KS-487 Rivals Angiopep-2 in BBB Penetration with Enhanced Selectivity

Living drugs: A wonderful evolution for therapeutic applications

Tumour-resident oncolytic bacteria trigger potent anticancer effects through selective intratumoural thrombosis and necrosis

Reply to “Exploring Bacteria‐Based Cancer Immunotherapy”—Comment on “Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics”

Hybrid nanoarchitectonics with bacterial component-integrated graphene oxide for cancer photothermo-chemo-immunotherapy

Multifunctional Magnetic Ionic Liquid‐Carbon Nanohorn Complexes for Targeted Cancer Theranostics

Multifunctional Magnetic Ionic Liquid‐Carbon Nanohorn Complexes for Targeted Cancer Theranostics

Biomimetic Functional Nanocomplexes for Photothermal Cancer Chemoimmunotheranostics

KS‐133/KS‐487 Nanoparticles Exhibit Potent Antitumor Effects through Synergistic LRP1 Targeting and VIPR2 Inhibition: Therapeutic Nanoarchitectonics for Solid Tumors

Tumor-isolated Cutibacterium acnes as an effective tumor suppressive living drug

Liquid metal–polymer nano-microconjugations as an injectable and photo-activatable drug carrier

Photocatalytic scaffolds enhance anticancer performances of bacterial consortium AUN

Wireless Light‐Emitting Diode‐Driven Functional Microneedle Devices for Skin Cancer Therapy

Cancer immunotheranostics using bioactive nanocoated photosynthetic bacterial complexes

Light‐Activatable Liquid Metal Immunostimulants for Cancer Nanotheranostics

Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics

Photocrosslinked Co‐Assembled Amino Acid Nanoparticles for Controlled Chemo/Photothermal Combined Anticancer Therapy

Nanoengineered Bifidobacterium bifidum with Optical Activity for Photothermal Cancer Immunotheranostics

Carbon nanohorn coating by electrodeposition accelerate bone formation on titanium implant

Convergence of Liquid Metal Biotechnologies for Our Health

Gallium-Based Liquid Metal Particles for Therapeutics

Optically activatable photosynthetic bacteria-based highly tumor specific immunotheranostics

Photothermogenetic inhibition of cancer stemness by near-infrared-light-activatable nanocomplexes

Innenrücktitelbild: Rational Chemical Multifunctionalization of Graphene Interface Enhances Targeted Cancer Therapy (Angew. Chem. 33/2020)

Collaborators (4)

Eri Hirata

Robin Rajan

Cécilia Ménard‐Moyon

Yuta Takano

Make your next move.